Commonwealth Equity Services
OKUR

Commonwealth Equity Services’s OnKure Therapeutics OKUR Stock Holding History

Commonwealth Equity Services’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,935
Closed -$33K – 4235
2024
Q3 		$33K Hold
1,935
– – ﹤0.01% 3969
2024
Q2 		$29K Hold
1,935
– – ﹤0.01% 3946
2024
Q1 		$32K Hold
1,935
– – ﹤0.01% 3932
2023
Q4 		$31K Hold
1,935
– – ﹤0.01% 3794
2023
Q3 		$147K Hold
1,935
– – ﹤0.01% 3481
2023
Q2 		$127K Sell
1,935
-300
-13% -$24.2K ﹤0.01% 3534
2023
Q1 		$133 Hold
2,235
– – ﹤0.01% 3435
2022
Q4 		$52K Hold
2,235
– – ﹤0.01% 3513
2022
Q3 		$74K Hold
2,235
– – ﹤0.01% 3429
2022
Q2 		$59K Hold
2,235
– – ﹤0.01% 3461
2022
Q1 		$65K Buy
+2,235
New +$125K ﹤0.01% 3553

Other funds holding OKUR

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Commonwealth Equity Services's OKUR Position: Q4 2024 in Review

Commonwealth Equity Services sold out of OnKure Therapeutics (OKUR) in Q4 2024, closing a stake of 1,935 shares — an estimated $33K sold.

Commonwealth Equity Services first reported a position in OKUR in Q1 2022 and held it in 11 quarters. The position peaked at $147K in Q3 2023. 51 funds tracked by Wall St. Rank hold OKUR as of Q4 2024.

  • Commonwealth Equity Services reported no remaining OnKure Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,935 OnKure Therapeutics shares in Q4 2024, an estimated $33K.
  • Commonwealth Equity Services first reported a position in OnKure Therapeutics in Q1 2022 and held it in 11 quarters.
  • Commonwealth Equity Services's OnKure Therapeutics position peaked at $147K in Q3 2023.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2024.

Based on Commonwealth Equity Services's 13F filing for Q4 2024, filed 10 Feb 2025.